About PhRMA
The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country’s leading innovative biopharmaceutical research companies, which are laser focused on developing innovative medicines that transform lives and create a healthier world. Together, we are fighting for solutions to ensure patients can access and afford medicines that prevent, treat and cure disease. Over the last decade, PhRMA member companies have invested more than $850 billion in the search for new treatments and cures, and they support nearly five million jobs in the United States.
Connect with PhRMA
For information on how innovative medicines save lives, please visit:
www.PhRMA.org
www.VotersforCures.org
www.AmericasMedicines.com
www.Facebook.com/PhRMA
www.X.com/PhRMA
PhRMA submitted comments in response to the Centers for Medicare & Medicaid Services (CMS) draft guidance for implementation of the prescription drug price-setting program established under the Inflation Reduction Act. Unfortunately, rather than using their authority to mitigate the program’s harmful impact on patients and innovation, CMS has doubled down on the previous administration’s misguided approach.
PhRMA Comments on Draft Guidance of Medicare Drug Price Negotiation Program preview
Fact Sheet
Medicare
Government Price Setting
PhRMA Comments on Draft Guidance of Medicare Drug Price Negotiation Program: IPAY 2028
PhRMA Comments on Draft Guidance of Medicare Drug Price Negotiation Program preview